Memphis Pharmaceuticals Total Risk Alpha

MPCI Stock   52.25  0.47  0.89%   
Memphis Pharmaceuticals total-risk-alpha technical analysis lookup allows you to check this and other technical indicators for Memphis Pharmaceuticals or any other equities. You can select from a set of available technical indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations and data normalization technicques. Please check also Equity Screeners to view more equity screening tools
  
Memphis Pharmaceuticals has current Total Risk Alpha of 0.5101. The total risk alpha measures the performance of an asset by comparing its returns with those of a selected benchmark portfolio.

Total Risk Alpha

 = 

RFR + (ER[b] - ER[a])

x

STD[a] / STD[b]

 = 
0.5101
ER[a] = Expected return on investing in Memphis Pharmaceuticals
ER[b] = Expected return on market index or selected benchmark
STD[a] =   Standard Deviation of returns on Memphis Pharmaceuticals
STD[b] = Standard Deviation of selected market or benchmark
RFR = Risk Free Rate of return. Typically T-Bill Rate

Memphis Pharmaceuticals Total Risk Alpha Peers Comparison

Memphis Total Risk Alpha Relative To Other Indicators

Memphis Pharmaceuticals is regarded second in total risk alpha category among its peers. It is considered to be number one stock in maximum drawdown category among its peers reporting about  92.50  of Maximum Drawdown per Total Risk Alpha. The ratio of Maximum Drawdown to Total Risk Alpha for Memphis Pharmaceuticals is roughly  92.50 
The benchmark portfolio represents the market risk matched to the total risk of the stock ETF or fund.
Compare Memphis Pharmaceuticals to Peers

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas